A placebo-controlled double-blind study of epalrestat (ONO-2235) in patients with diabetic neuropathy

Diabet Med. 1993:10 Suppl 2:39S-43S. doi: 10.1111/j.1464-5491.1993.tb00197.x.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Multicenter Study

MeSH terms

  • Adult
  • Aldehyde Reductase / antagonists & inhibitors*
  • Diabetic Neuropathies / blood
  • Diabetic Neuropathies / drug therapy*
  • Diabetic Neuropathies / physiopathology
  • Double-Blind Method
  • Glycated Hemoglobin / analysis
  • Humans
  • Median Nerve / drug effects
  • Median Nerve / physiopathology
  • Middle Aged
  • Neural Conduction / drug effects
  • Peroneal Nerve / drug effects
  • Peroneal Nerve / physiopathology
  • Placebos
  • Rhodanine / analogs & derivatives*
  • Rhodanine / therapeutic use
  • Thiazolidines

Substances

  • Glycated Hemoglobin A
  • Placebos
  • Thiazolidines
  • epalrestat
  • Rhodanine
  • Aldehyde Reductase